A gene therapy mystery? GenSight blasted as 1st PhIII eye study ends in an intriguing failure – Endpoints News
Endpoints NewsA gene therapy mystery? GenSight blasted as 1st PhIII eye study ends in an intriguing failureEndpoints NewsThe mystery: The other eyes that received a sham therapy did just as well with their eyesight. Exactly as well. That makes the Phas… Continue reading
